2Arthritis Advisory Committee.
Safety update on the TNF-alpha antagonists. Open session of the Food and Drug Administration Center for Biologics Evaluation and Research;
2001 Aug 17; Gaithersburg (MD). Online at http:www.fda.gov/ohrms/dockets/ac/01/transcripts/3779t2_01.pdf.
5Charles PJ,
Smeenk RJ,
De Jong J,
Feldmann M,
Maini RN.
Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Arthritis Rheum2000;
43:
2383–90.
Please check your email for instructions on resetting your password.
If you do not receive an email within 10 minutes, your email address may not be registered,
and you may need to create a new Wiley Online Library account.
Request Username
Can't sign in? Forgot your username?
Enter your email address below and we will send you your username
If the address matches an existing account you will receive an email with instructions to retrieve your username
The full text of this article hosted at iucr.org is unavailable due to technical difficulties.
